Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms.

familial malignancies myeloproliferative relatives

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
May 2022
Historique:
received: 11 03 2022
revised: 11 03 2022
accepted: 11 03 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

In a cohort of 3131 patients with myeloproliferative neoplasms (MPNs), we identified 200 patients (6.4%) who reported a second case of haematological malignancies (HM) in first- or second-degree relatives. The occurrence of a second HM in the family was not influenced by MPN subtype, sex or driver mutation, while it was associated with age at MPN diagnosis: 8.5% of patients diagnosed with MPN younger than 45 years had a second relative affected with HM compared to 5.5% of those diagnosed at the age of 45 years or older (

Identifiants

pubmed: 35846061
doi: 10.1002/jha2.425
pii: JHA2425
pmc: PMC9176120
doi:

Types de publication

Journal Article

Langues

eng

Pagination

475-479

Informations de copyright

© 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Br J Haematol. 2021 Jun;193(6):1134-1141
pubmed: 34002362
J Clin Oncol. 2017 Mar 20;35(9):1018-1028
pubmed: 28297620
Blood. 2008 Sep 15;112(6):2199-204
pubmed: 18451307
Blood. 2017 Dec 7;130(23):2475-2483
pubmed: 29212804
Haematologica. 2011 Mar;96(3):454-8
pubmed: 21109692
Blood. 2019 Sep 19;134(12):960-969
pubmed: 31395603
Radiat Res. 2013 Mar;179(3):361-82
pubmed: 23398354
Nature. 2019 Jan;565(7739):312-317
pubmed: 30602793
Blood. 2011 Dec 15;118(25):6515-20
pubmed: 22039256
Nucleic Acids Res. 2013 Apr;41(7):e89
pubmed: 23471004
Am J Hematol. 2014 Aug;89(8):E125-32
pubmed: 24753145
J Clin Oncol. 2007 Dec 10;25(35):5630-5
pubmed: 17998545
Blood. 2018 Aug 30;132(9):973-976
pubmed: 29991558
Blood. 2014 Apr 10;123(15):2416-9
pubmed: 24553179
Br J Haematol. 2017 Sep;178(5):689-698
pubmed: 28444727

Auteurs

Daniele Vanni (D)

Department of Molecular Medicine University of Pavia Pavia Italy.

Oscar Borsani (O)

Department of Molecular Medicine University of Pavia Pavia Italy.
Division of Haematology Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Yasuhito Nannya (Y)

Department of Pathology and Tumor Biology Kyoto University Kyoto Japan.
Division of Hematopoietic Disease Control The Institute of Medical Sciences The University of Tokyo Tokyo Japan.

Emanuela Sant'Antonio (E)

Division of Haematology Azienda USL Toscana Nord Ovest Lucca Italy.

Chiara Trotti (C)

Department of Molecular Medicine University of Pavia Pavia Italy.

Ilaria Carola Casetti (IC)

Department of Molecular Medicine University of Pavia Pavia Italy.

Daniela Pietra (D)

Division of Haematology Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Anna Gallì (A)

Division of Haematology Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Silvia Zibellini (S)

Division of Haematology Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Virginia Valeria Ferretti (VV)

Service of Clinical Epidemiology and Biostatistics Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Luca Malcovati (L)

Department of Molecular Medicine University of Pavia Pavia Italy.
Division of Haematology Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology Kyoto University Kyoto Japan.

Luca Arcaini (L)

Department of Molecular Medicine University of Pavia Pavia Italy.
Division of Haematology Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Elisa Rumi (E)

Department of Molecular Medicine University of Pavia Pavia Italy.
Division of Haematology Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Pavia Italy.

Classifications MeSH